Related Experiment Video
Updated: Jul 14, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Apoptotic action of E2F1 requires glycogen synthase kinase 3-beta activity in PC12 cells
Lilia Espada1, Basavaraj Udapudi1, Petar Podlesniy1
1Departament de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Catalunya, SpainLaboratori de Neuropatologia Molecular, Departament de Ciències Mèdiques Básiques, Universitat de Lleida, Lleida, Catalunya, SpainCentre d'Oncologia Molecular, Institut de Recerca Oncologica-Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Catalunya, Spain.
Abstract:
Both E2F1 and GSK3beta have been described as essential targets in neuronal apoptosis. Previous studies have demonstrated that GSK3beta binds to E2F1 in vivo. We wanted to investigate whether these proteins could share a common apoptotic signal pathway in neuronal cells. With this intention, we developed a PC12 ER-E2F1 stable cell line in which E2F1 activity was dependent on the presence of 4-hydroxitamoxifen. E2F1 activation produced apoptosis in naive and post-mitotic cells; serum and nerve growth factor respectively protected them from E2F1 apoptotic stimuli. The presence of specific GSK3beta inhibitors SB216763 and LiCl completely protected cells from apoptosis induced by E2F1 activation. In addition, knocked down GSK3beta experiments by small interference RNAs have demonstrated that a reduction of GSK3beta protein levels can lower the apoptotic effect of E2F1. Finally, we demonstrated that the apoptotic effect of E2F1 is not due to the regulation of GSK3beta activity, and that the inhibitory effect of GSK3beta inhibitor SB216763 on E2F1 induced apoptosis could be due to an alteration in the E2F1-regulated transcription gene pattern. In summary, we have demonstrated that the apoptotic action of E2F1 requires GSK3beta activity.
Insights
The apoptotic action of E2F1 in neuronal cells requires Glycogen Synthase Kinase 3 beta (GSK3beta) activity. Inhibiting GSK3beta prevents E2F1-induced neuronal apoptosis, highlighting a shared pathway.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- E2F1 and GSK3beta are key targets in neuronal apoptosis.
- GSK3beta has been shown to bind E2F1 in vivo.
Purpose of the Study:
- Investigate if E2F1 and GSK3beta share a common apoptotic pathway in neuronal cells.
- Elucidate the role of GSK3beta in E2F1-mediated neuronal apoptosis.
Main Methods:
- Developed a PC12 cell line with inducible E2F1 expression.
- Utilized GSK3beta inhibitors (SB216763, LiCl) and small interfering RNAs (siRNAs) for knockdown.
- Assessed apoptosis induction and gene expression patterns.
Main Results:
- E2F1 activation induced apoptosis in neuronal cells, which was blocked by GSK3beta inhibitors.
- Reduced GSK3beta levels via siRNA diminished E2F1-induced apoptosis.
- E2F1-induced apoptosis was independent of GSK3beta activity regulation but potentially linked to altered gene transcription.
Conclusions:
- GSK3beta activity is essential for E2F1-mediated neuronal apoptosis.
- The findings reveal a critical role for GSK3beta in the E2F1 apoptotic pathway.
Related Concept Videos
Cell Specific Gene Expression
Negative Regulator Molecules
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
cAMP-dependent Protein Kinase Pathways

